Spero Therapeutics
SPRO
$1.54
Share price
8.80%
Change (1 day)
-16.49%
Change (1 year)
Categories
Spero Therapeutics (SPRO) - Total debt
Total debt on the balance sheet as of December 2023 : $5.54 M
According to Spero Therapeutics's latest financial reports the company's total debt is $5.54 M. A company’s total debt is the sum of all current and non-current debts.
Spero Therapeutics - Total debt on balance sheet (from 2018 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $5.54 M | -16.61% |
| 2022-12-31 | $6.64 M | -9.38% |
| 2021-12-31 | $7.33 M | -6.42% |
| 2020-12-31 | $7.83 M | 41.35% |
| 2019-12-31 | $5.54 M | |
| 2018-12-31 | $N/A |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 IBM IBM | $59.93 B | 1,081,173.68% | 🇺🇸 USA |
 Thomson Reuters
TRI | $3.54 B | 63,800.41% | 🇨🇦 Canada |
 Franklin Covey FC | $11.14 M | 101.06% | 🇺🇸 USA |